These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6082239)

  • 1. Identification of osteolytic sterols in human breast cancer.
    Gordan GS; Fitzpatrick ME; Lubich WP
    Trans Assoc Am Physicians; 1967; 80():183-9. PubMed ID: 6082239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant neoplasms and calcium metabolism (a review of the literature)].
    Kashulina AP; Tereshchenko IP
    Patol Fiziol Eksp Ter; 1973; 17(5):84-8. PubMed ID: 4789470
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating phytosterols in normal females, lactating mothers and breast cancer patients.
    Haddad JG; Couranz SJ; Avioli LV
    J Clin Endocrinol Metab; 1970 Feb; 30(2):174-80. PubMed ID: 5461043
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteolytic sterol in human breast cancer.
    Gordon GS; Cantino RJ; Erhardt L; Hansen J; Lubich W
    Science; 1966 Mar; 151(3715):1226-8. PubMed ID: 4286341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor sterols.
    Day EA; Malcom GT; Beeler MF
    Metabolism; 1969 Aug; 18(8):646-51. PubMed ID: 5799287
    [No Abstract]   [Full Text] [Related]  

  • 7. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorbability of beta-sitosterol in humans.
    Gould RG; Jones RJ; LeRoy GV; Wissler RW; Taylor CB
    Metabolism; 1969 Aug; 18(8):652-62. PubMed ID: 5799288
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer and concomitant primary hyperparathyroidism: description of two patients.
    Kara IO; Sahin B; Yapar Z
    Acta Med Austriaca; 2004 Aug; 31(3):81-4. PubMed ID: 15515483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice.
    Awad AB; Downie A; Fink CS; Kim U
    Anticancer Res; 2000; 20(2A):821-4. PubMed ID: 10810360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone resorption activity of osteolytic metastatic lung and breast cancers.
    Shih LY; Shih HN; Chen TH
    J Orthop Res; 2004 Nov; 22(6):1161-7. PubMed ID: 15475192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Dickkopf-1 expression in breast cancer bone metastases.
    Voorzanger-Rousselot N; Goehrig D; Journe F; Doriath V; Body JJ; Clézardin P; Garnero P
    Br J Cancer; 2007 Oct; 97(7):964-70. PubMed ID: 17876334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C; Racanelli A
    Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of dietary plant sterols in man and experimental animals.
    Subbiah MT
    Mayo Clin Proc; 1971 Aug; 46(8):549-59. PubMed ID: 4935725
    [No Abstract]   [Full Text] [Related]  

  • 17. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients.
    Theriault R
    Br J Clin Pract Suppl; 1996 Sep; 87():8-12; discussion 13-4. PubMed ID: 8995011
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbances of calcium metabolism in the cancer patient.
    Pearson OH
    Proc Natl Cancer Conf; 1964; 5():445-50. PubMed ID: 5856173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.